Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

New England Journal of Medicine - Tập 377 Số 14 - Trang 1345-1356 - 2017
Jedd D. Wolchok1, Vanna Chiarion‐Sileni2, René González3, Piotr Rutkowski4, Jean‐Jacques Grob5, C. Lance Cowey6, Christopher D. Lao7, John Wagstaff8, Dirk Schadendorf9, Pier Francesco Ferrucci10, Michael Smylie11, Reinhard Dummer12, Andrew G. Hill13, David Hogg14, John B.A.G. Haanen15, Matteo S. Carlino16, Oliver Bechter17, Michele Maio18, Iván Marquez‐Rodas19, Massimo Guidoboni20, Grant A. McArthur21, Célèste Lebbé22, Paolo A. Ascierto23, Georgina V. Long24, Jonathan Cebon25, Jeffrey A. Sosman26, Michael A. Postow1, Margaret K. Callahan1, Dana Walker27, Linda Rollin27, Rafia Bhore27, F. Stephen Hodi28, James Larkin29
1Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York
2Padua
3University of Colorado, Denver
4Maria Sklodowska-Curie Institute, Oncology Center, Warsaw, Poland
5Aix-Marseille University, Hôpital de la Timone, Marseille
6Texas Oncology–Baylor Cancer Center, Dallas
7University of Michigan, Ann Arbor
8College of Medicine, Swansea University, Swansea
9German Cancer Consortium, Heidelberg — both in Germany
10European Institute of Oncology, Milan
11Cross Cancer Institute, Edmonton, AB
12Universitäts Spital, Zurich, Switzerland, Melbourne, VIC
13Tasman Oncology Research, Southport Gold Coast, QLD, Melbourne, VIC
14Princess Margaret Cancer Centre, Toronto
15Netherlands Cancer Institute, Amsterdam
16Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney, Melbourne, VIC
17University Hospitals Leuven, KU Leuven, Leuven, Belgium
18Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena
19General University Hospital Gregorio Marañón, Madrid
20Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
21Sydney, and Peter MacCallum Cancer Centre, Melbourne, VIC
22Assistance Publique–Hôpitaux de Paris, Dermatology and Centres d’Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris
23Istituto Nazionale Tumori Fondazione Pascale, Naples
24Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Melbourne, VIC
25Olivia Newton-John Cancer Research Institute, University of Melbourne, Melbourne, VIC
26Northwestern University, Chicago
27Bristol-Myers Squibb, Princeton, NJ
28Dana Farber Cancer Institute, Boston
29Royal Marsden NHS Foundation Trust, London

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1056/NEJMoa1003466

10.1056/NEJMoa1104621

10.1200/JCO.2014.56.2736

10.1056/NEJMoa1504030

10.1056/NEJMoa1503093

Robert C, 2017, J Clin Oncol, 15, 35

10.1056/NEJMoa1414428

10.1016/S1470-2045(16)30366-7

10.1093/biomet/75.4.800

10.1111/j.0006-341X.2000.00337.x

10.1111/j.1365-2753.2005.00598.x

Long GV, Ann Oncol